Aurobindo Pharma Ltd has unveiled today their new Logo and Corporate Identity at a ceremony in Hyderabad.

Speaking on the occasion, P V Rama Prasad Reddy, chairman, of the company said, "We are proud to introduce our new corporate identity. Our new Logo is intended to better reflect the value and personality of the Group as we expand - speed, simplicity and synergy. It also shows that we are as strong and progressive as ever, and that we are constantly increasing our knowledge and skills better to serve our clients. The new identity, dynamism and excellence will bring a sense of rejuvenation and growth to the company and its employees". He further added "Our vision is to become a leading provider of generic pharmaceuticals from Asia by 2015." Our immediate goal is to surpass US$ 1 bio landmark in two to three years. The company has just crossed the US$ 500 mio landmark.

The company is a fully integrated pharmaceutical company in the global arena exporting pharmaceuticals to over 100 countries. The company has come a long way in the last 20 years. It has built a robust product portfolio to capture sizeable market share in the world through rapid filing of process patents, DMFs, ANDAs.

Aurobindo is one amongst the top in the world in terms of DMF filings in USA, a major Landmark to reflect the creation of intellectual property. Six therapeutic areas and seven formulation technology platforms are driving the growth by quantums. The company is an equal opportunity employer and has over 30 nationalities working across the globe. The company is closer to customers with several subsidiaries and branches established acros and is local in each country with significant local people manning the operations.

The company's targeted manufacturing infrastructure is approved by all leading regulatory agencies in the world and the formulations are accepted across the world - for example, every leading wholesaler chain and distributor is a client of the company.